Skip to main content
Cambodia Hep-C
War in Gaza:: find out how we're responding
Learn more
Worldwide, an estimated 58 million people are infected with the hepatitis C virus, with about 1.5 million new infections occurring per year.

While hepatitis C can be cured, few people have access to treatment.  

A blood-borne virus that attacks the liver, hepatitis C kills hundreds of thousands of people each year, mostly from resulting complications, usually cirrhosis or liver cancer.

While hepatitis C is found worldwide, the vast majority of people with the disease live in developing countries; China, India, Egypt, and Indonesia are particularly affected.

Hepatitis C is a curable disease, but millions don't have access to treatment due to high prices.


MSF Access Campaign

Quick facts about hepatitis C

When Big Pharma plays for keeps, who wins and who loses? (ENG)

When Big Pharma plays for keeps, who wins and who loses? (ENG)

When Big Pharma plays for keeps, who wins and who loses?

In this video, we follow the development of sofosbuvir, a true breakthrough drug for hepatitis C, a severe virus that attacks the liver and can be deadly.

The story of sofosbuvir illustrates how research and development for new prescription drugs really works.

After a scientist who got millions in tax-dollars started a small company that did the long work of discovering a new medicine, and showed that it was safe and effective, a giant corporation bought up the next big blockbuster drug and cashed in.

As the new owner of sofosbuvir, Gilead continued clinical trials to learn more about the drug’s effectiveness, safety, side-effects and dosage before seeking government approval to bring the new drug to market.

Gilead first set the price for sofosbuvir at $1000 per pill. That made its worth per gram 67 times greater than gold, but research shows that it only costs $42 to produce.

Hepatitis C - Clinic Cambodia
Hepatitis C

Public health partnership launched to tackle silent epidemic of hepatitis C

Press Release 27 Jul 2021
Pakistan: Meeting regular health needs amid the COVID-19 pandemic

Meeting regular health needs amid the COVID-19 pandemic in Pakistan

Project Update 8 Sep 2020
Out of Darkness- fighting Hepatitis C
Hepatitis C

Increasing access to hepatitis C treatment in Ukraine

Project Update 2 Jun 2020
MSF’s Hepatitis C Clinic in Machar Colony, Karachi

Working to turn the tide of hepatitis C in Karachi’s Machar Colony

Project Update 20 Sep 2019
Kim Kholling (50)
Photo Story

Putting people at the centre of TB, HIV and hepatitis treatment in Manipur

30 Jul 2019
Photo Story
Hepatitis C treatment in Mykolaiv

Effective drugs and patient support to combat Ukraine’s hepatitis C epidemic

Project Update 25 Jul 2019
Hepatitis C active case finding

Affordable drugs and new hepatitis C treatment method save lives

Project Update 24 Jul 2019
Essential Hepatitis C medicine Sofosbuvir and Daclatasvir
Hepatitis C

Appeal lodged against decision to uphold Gilead’s patent on hepatitis C drug

Press Release 5 Dec 2018
Out of Darkness- fighting Hepatitis C

"I am one of you: I live with HIV and used to live with hepatitis C"

Voices from the Field 30 Nov 2018
Advanced HIV management in Homa Bay
Medical Resource

MSF Field Research

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. All of these articles can be found on our dedicated Field Research website.

Visit site